Company intelligence / Profile preview

BioXceed

San Francisco, California, United Statesarchive.bio.org ↗

Ownership: Private
Employees: ~4
Development stage: Other

Overview

BioXceed provides advanced cGMP labs, cleanrooms, and expert support for early to mid-stage drug development. It enables biotech companies to accelerate preclinical and early clinical manufacturing with in-house control over process optimization, supply chain management, tech transfer, and regulatory compliance. The company does not develop its own drugs but serves as an accelerator/CDMO for others.

Therapeutic areas: Other
Modalities: Not specified; supports a range of drug therapy modalities for early-mid stage development
Industry: Contract Manufacturing Organization

Partnerships

None publicly disclosed as major pharma/biotech partnerships; operates as an independent accelerator/CDMO supporting multiple clients

Beyond the preview

Go deeper on BioXceed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioXceed.

Explore the full profile